Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders

Nature Reviews Neuroscience

Volumn 11, Issue 10, 2010, Pages 682-696

  Hardingham, Giles E ^a   Bading, Hilmar ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALPAIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIZOCILPINE; GLUTAMIC ACID; GLUTATHIONE; HUNTINGTIN; MEMANTINE; MITOGEN ACTIVATED PROTEIN KINASE 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE INHIBITOR; THIOREDOXIN; TRANSCRIPTION FACTOR FOXO;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL SURVIVAL; DEGENERATIVE DISEASE; EXCITOTOXICITY; GENE EXPRESSION; GENE REPRESSION; GENOMICS; HUMAN; HUNTINGTON CHOREA; INTRACELLULAR SIGNALING; LOW DRUG DOSE; MITOCHONDRION; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; REVIEW; SYMPATHETIC NERVE; SYNAPTIC TRANSMISSION;

ANIMALS; CELL DEATH; GENE EXPRESSION; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 77956917231     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn2911     Document Type: Review

References (162)

1. Aamodt, S. M. & Constantine-Paton, M. The role of neural activity in synaptic development and its implications for adult brain function. Adv. Neurol. 79, 133-144 (1999).
2. Bliss, T. V. & Collingridge, G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39 (1993).
3. Tovar, K. R. & Westbrook, G. L. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 4180-4188 (1999).
4. Rosenmund, C., Feltz, A. & Westbrook, G. L. Synaptic NMDA receptor channels have a low open probability. J. Neurosci. 15, 2788-2795 (1995).
5. Cottrell, J. R., Dube, G. R., Egles, C. & Liu, G. Distribution, density, and clustering of functional glutamate receptors before and after synaptogenesis in hippocampal neurons. J. Neurophysiol. 84, 1573-1587 (2000).
6. Petralia, R. S., et al. Organization of NMDA receptors at extrasynaptic locations. Neuroscience 167, 68-87 (2010).
7. Rusakov, D. A. & Kullmann, D. M. Extrasynaptic glutamate diffusion in the hippocampus: ultrastructural constraints, uptake, and receptor activation. J. Neurosci. 18, 3158-3170 (1998).
8. Massey, P. V., et al. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical longterm potentiation and long-term depression. J. Neurosci. 24, 7821-7828 (2004).
9. 2+ channel-dependent long-term depression in the juvenile superior colliculus. J. Neurosci. 27, 13649-13654 (2007).
10. Lucas, D. R. & Newhouse, J. P. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch. Ophthalmol. 58, 193-201 (1957).
11. Curtis, D. R., Phillis, J. W. & Watkins, J. C. Chemical excitation of spinal neurones. Nature 183, 611-612 (1959).
12. Olney, J. W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721 (1969).
13. Choi, D. W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7, 369-379 (1987).
14. Choi, D. W., Maulucci-Gedde, M. & Kriegstein, A. R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368 (1987).
15. Choi, D. W., Koh, J. Y. & Peters, S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8, 185-196 (1988).
16. Tymianski, M., Charlton, M. P., Carlen, P. L. & Tator, C. H. Source specificity of earlly calcium neurotoxicity in cultures embryonic spinal neurons. J. Neurosci. 13, 2085-2104 (1993).
17. Rothman, S. M. & Olney, J. W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19, 105-111 (1986).
18. Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634 (1988).
19. Lipton, S. A. & Rosenberg, P. A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-621 (1994).
20. Arundine, M. & Tymianski, M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657-668 (2004).
21. Dawson, T. M., Zhang, J., Dawson, V. L. & Snyder, S. H. Nitric oxide: cellular regulation and neuronal injury. Prog. Brain Res. 103, 365-369 (1994).
22. Camacho, A. & Massieu, L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 37, 11-18 (2006).
23. Fan, M. M. & Raymond, L. A. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntingtons disease. Prog. Neurobiol. 81, 272-293 (2007).
24. Kalia, L. V., Kalia, S. K. & Salter, M. W. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 7, 742-755 (2008).
25. Ikonomidou, C. & Turski, L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383-386 (2002).
26. Hetman, M. & Kharebava, G. Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6, 787-799 (2006).
27. Hardingham, G. E. Pro-survival signalling from the NMDA receptor. Biochem. Soc. Trans. 34, 936-938 (2006).
28. Gould, E., Cameron, H. A. & McEwen, B. S. Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus. J. Comp. Neurol. 340, 551-565 (1994).
29. Ikonomidou, C., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283, 70-74 (1999). (Pubitemid 29044848)
30. Pohl, D., et al. NMDA antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc. Natl Acad. Sci. USA 96, 2508-2513 (1999).
31. Monti, B. & Contestabile, A. Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum. Eur. J. Neurosci. 12, 3117-3123 (2000).
32. Adams, S. M., de Rivero Vaccari, J. C. & Corriveau, R. A. Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. J. Neurosci. 24, 9441-9450 (2004).
33. Ikonomidou, C., Stefovska, V. & Turski, L. Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc. Natl Acad. Sci. USA 97, 12885-12890 (2000).
34. Tashiro, A., Sandler, V. M., Toni, N., Zhao, C. & Gage, F. H. NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus. Nature 442, 929-933 (2006).
35. Lipton, S. A. & Kater, S. B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12, 265-270 (1989).
36. Lipton, S. A. & Nakanishi, N. Shakespeare in Love - with NMDA receptors? Nature Med. 5, 270-271 (1999).
37. Hardingham, G. E. & Bading, H. The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 26, 81-89 (2003).
38. Hardingham, G. E., Fukunaga, Y. & Bading, H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nature Neurosci. 5, 405-414 (2002).
39. Leveille, F., et al. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 22, 4258-4271 (2008).
40. Stanika, R. I., et al. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc. Natl Acad. Sci. USA 106, 9854-9859 (2009).
41. Ivanov, A., et al. Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the ERK activity in cultured rat hippocampal neurons. J. Physiol. 572, 789-798 (2006).
42. Zhang, S. J., et al. Decoding NMDA Receptor Signaling: identification of genomic programs specifying neuronal survival and death. Neuron 53, 549-562 (2007).
43. Papadia, S., et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nature Neurosci. 11, 476-487 (2008).
44. Okamoto, S., et al. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nature Med. 15, 1407-1413 (2009).
45. Soriano, F. X., et al. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci. 26, 4509-4518 (2006).
46. Isacson, O. On neuronal health. Trends Neurosci. 16, 306-308 (1993).
47. 2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J. Neurosci. 25, 4279-4287 (2005).
48. Morgan, J. I., Cohen, D. R., Hempstead, J. L. & Curran, T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237, 192-197 (1987).
49. Cole, A. J., Saffen, D. W., Baraban, J. M. & Worley, P. F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 340, 474-476 (1989).
50. Hardingham, G. E., Arnold, F. J. & Bading, H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nature Neurosci. 4, 261-267 (2001).
51. Zhang, S. J., et al. Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity. PLoS Genet. 5, e1000604 (2009).
52. Chrivia, J. C., et al. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859 (1993).
53. 2+/ calmodulindependent protein kinase IV. Role in transcriptional regulation. J. Biol. Chem. 269, 15520-15527 (1994).
54. Kwok, R. P. S., et al. Nuclear protein CBP is coactivator for the transcription factor CREB. Nature 370, 223-226 (1994).
55. Matthews, R. P., et al. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol. 14, 6107-6116 (1994).
56. 2+/calmodulindependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8, 2527-2539 (1994).
57. Hardingham, G. E., Chawla, S., Johnson, C. M. & Bading, H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385, 260-265 (1997).
58. Chawla, S., Hardingham, G. E., Quinn, D. R. & Bading, H. CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science 281, 1505-1509 (1998).
59. Bonni, A., et al. Cell survival promoted by the Ras- MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362 (1999).
60. Mayr, B. & Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Rev. Mol. Cell Biol. 2, 599-609 (2001).
61. Lonze, B. E., Riccio, A., Cohen, S. & Ginty, D. D. Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34, 371-385 (2002).
62. Mantamadiotis, T., et al. Disruption of CREB function in brain leads to neurodegeneration. Nature Genetics 31, 47-54 (2002).
63. Carlezon, W. A., Jr, Duman, R. S. & Nestler, E. J. The many faces of CREB. Trends Neurosci. 28, 436-445 (2005).
64. Lee, B., Butcher, G. Q., Hoyt, K. R., Impey, S. & Obrietan, K. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine J. Neurosci. 25 1137-1148 (2005)
65. Limback-Stokin, K., Korzus, E., Nagaoka-Yasuda, R. & Mayford, M. Nuclear calcium/calmodulin regulates memory consolidation. J. Neurosci. 24, 10858-10867 (2004).
66. Lau, D. & Bading, H. Synaptic activity-mediated suppression of p53 and induction of nuclear calciumregulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition. J. Neurosci. 29, 4420-4429 (2009).
67. Leveille, F., et al. Suppression of the intrinsic apoptosis pathway by synaptic activity. J. Neurosci. 30, 2623-2635 (2010).
68. Favaron, M., et al. NMDA-stimulated expression of BDNF mRNA in cultured cerebellar granule neurones. Neuroreport 4, 1171-1174 (1993).
69. Jiang, X., et al. The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J. Neurochem. 94, 713-722 (2005).
70. Thoenen, H., Barde, Y. A., Davies, A. M. & Johnson, J. E. Neurotrophic factors and neuronal death. Ciba Found. Symp. 126, 82-95 (1987).
71. Hansen, H. H., et al. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol. Dis. 16, 440-453 (2004).
72. Vashishta, A., et al. Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptorstimulated cortical neurons. J. Neurosci. 29, 15331-15340 (2009).
73. Zheng, S., et al. NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice. J. Clin. Invest. 120, 2446-2456 (2010).
74. Shinoda, S., et al. Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy. J. Clin. Invest. 113, 1059-1068 (2004).
75. Lehtinen, M. K., et al. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125, 987-1001 (2006).
76. Salih, D. A. & Brunet, A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 20, 126-136 (2008).
77. Dick, O. & Bading, H. Synaptic activity and nuclear calcium signaling protects hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic NMDA receptors. 19 Apr 2010 J. Biol. Chem. (doi:10.1074/jbc. M110.127654).
78. Al-Mubarak, B., Soriano, F. X. & Hardingham, G. E. Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. Channels (Austin) 3, 233-238 (2009).
79. Biteau, B., Labarre, J. & Toledano, M. B. ATPdependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425, 980-984 (2003).
80. Chang, T. S., et al. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279, 50994-51001 (2004).
81. Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V. & Chumakov, P. M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596-600 (2004).
82. Soriano, F. X., et al. Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1, 2-dithiole-3-thione. J. Neurochem. 107, 533-543 (2008).
83. Rhee, S. G., Woo, H. A., Bae, S. H. & Park, S. Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins. Antioxid. Redox Signal. 11, 739-745 (2009).
84. Hardingham, G. E. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem. Soc. Trans. 37, 1147-1160 (2009).
85. Bading, H., Ginty, D. D. & Greenberg, M. E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260, 181-186 (1993).
86. Hardingham, G. E., Chawla, S., Cruzalegui, F. H. & Bading, H. Control of recruitment and transcriptionactivating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels. Neuron 22, 789-798 (1999).
87. Sala, C., Rudolph-Correia, S. & Sheng, M. Developmentally regulated NMDA receptordependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons. J. Neurosci. 20, 3529-3536 (2000).
88. Ghosh, A. & Greenberg, M. E. Calcium signalling in neurons: molecular mechanisms and cellular consequences. Science 268, 239-247 (1995).
89. Hardingham, G. E. & Bading, H. Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim. Biophys. Acta 1600, 148-153 (2002).
90. Dieterich, D. C., et al. Caldendrin-Jacob: a protein liaison that couples NMDA receptor signalling to the nucleus. PLoS Biol. 6, e34 (2008).
91. Chandler, L. J., Sutton, G., Dorairaj, N. R. & Norwood, D. N-methyl D-aspartate receptor-mediated bidirectional control of extracellular signal-regulated kinase activity in cortical neuronal cultures. J. Biol. Chem. 276, 2627-2636 (2001).
92. Bading, H. & Greenberg, M. E. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 253, 912-914 (1991).
93. Kim, M. J., Dunah, A. W., Wang, Y. T. & Sheng, M. Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46, 745-760 (2005).
94. Mulholland, P. J., Luong, N. T., Woodward, J. J. & Chandler, L. J. Brain-derived neurotrophic factor activation of extracellular signal-regulated kinase is autonomous from the dominant extrasynaptic NMDA receptor extracellular signal-regulated kinase shutoff pathway. Neuroscience 151, 419-427 (2008).
95. Xu, J., et al. Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J. Neurosci. 29, 9330-9343 (2009).
96. 2+ exchanger in excitotoxicity. Cell 120, 275-285 (2005).
97. Kawasaki, H., et al. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272, 18518-18521 (1997).
98. Cao, J., et al. Distinct requirements for p38α and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J. Biol. Chem. 279, 35903-35913 (2004).
99. Soriano, F. X., et al. Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J. Neurosci. 28, 10696-10710 (2008).
100. Okamoto, S., Krainc, D., Sherman, K. & Lipton, S. A. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl Acad. Sci. USA 97, 7561-7566 (2000).
101. Soriano, F. X., Leveille, F., Papadia, S., Bell, K. F. & Hardingham, G. E. Neuronal activity controls the antagonistic balance between PGC-1α and SMRT in regulating antioxidant defences. Antioxid. Redox Signal. (in the press).
102. Paul, S., Nairn, A. C., Wang, P. & Lombroso, P. J. NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nature Neurosci. 6, 34-42 (2003).
103. Wahl, A. S., et al. Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-Daspartate receptors. Neuroscience 158, 344-352 (2009).
104. Wittmann, M., et al. Synaptic activity induces dramatic changes in the geometry of the cell nucleus: interplay between nuclear structure, histone H3 phosphorylation, and nuclear calcium signaling. J. Neurosci. 29, 14687-14700 (2009).
105. Taddei, A., et al. Nuclear pore association confers optimal expression levels for an inducible yeast gene. Nature 441, 774-778 (2006).
106. Akhtar, A. & Gasser, S. M. The nuclear envelope and transcriptional control. Nature Rev. Genet. 8, 507-517 (2007).
107. Collins, M. O. & Grant, S. G. Supramolecular signalling complexes in the nervous system. Subcell. Biochem. 43, 185-207 (2007).
108. Aarts, M., et al. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298, 846-850 (2002).
109. Cao, J., et al. The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 168, 117-126 (2005).
110. Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N. & Jan, L. Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368, 144-147 (1994).
111. Zhong, J., Russell, S. L., Pritchett, D. B., Molinoff, P. B. & Williams, K. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol. Pharmacol. 45, 846-853 (1994).
112. Steigerwald, F., et al. C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors. J. Neurosci. 20, 4573-4581 (2000).
113. Groc, L., et al. NMDA receptor surface mobility depends on NR2A-2B subunits. Proc. Natl Acad. Sci. USA 103, 18769-18774 (2006).
114. Martel, M., Wyllie, D. J. & Hardingham, G. E. In developing hippocampal neurons, NR2B-containing NMDA receptors can mediate signalling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158, 334-343 (2009).
115. Thomas, C. G., Miller, A. J. & Westbrook, G. L. Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons. J. Neurophysiol. 95, 1727-1734 (2006).
116. Harris, A. Z. & Pettit, D. L. Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices. J. Physiol. 584, 509-519 (2007).
117. Liu, Y., et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857 (2007).
118. Weitlauf, C., et al. Activation of NR2A-containing NMDA receptors is not obligatory for NMDA receptordependent long-term potentiation. J. Neurosci. 25, 8386-8390 (2005).
119. Berberich, S., et al. Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. J. Neurosci. 25, 6907-6910 (2005).
120. Neyton, J. & Paoletti, P. Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach. J. Neurosci. 26, 1331-1333 (2006).
121. Frizelle, P. A., Chen, P. E. & Wyllie, D. J. A. Equilibrium constants for NVP-AAM077 acting at recombinant NR1/NR2A and NR1/NR2B NMDA receptors: implications for studies of synaptic transmission. Mol. Pharmacol. 70, 1022-1032 (2006).
122. de Marchena, J., et al. NMDA receptor antagonists reveal age-dependent differences in the properties of visual cortical plasticity. J. Neurophysiol. 100, 1936-1948 (2008).
123. von Engelhardt, J., et al. Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors. Neuropharmacology 53, 10-17 (2007).
124. Hatton, C. J. & Paoletti, P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46, 261-274 (2005).
125. Harris, A. Z. & Pettit, D. L. Recruiting extrasynaptic NMDA receptors augments synaptic signaling. J. Neurophysiol. 99, 524-533 (2008).
126. Groc, L., Bard, L. & Choquet, D. Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives. Neuroscience 158, 4-18 (2009).
127. Tovar, K. R. & Westbrook, G. L. Mobile NMDA receptors at hippocampal synapses. Neuron 34, 255-264 (2002).
128. Chen, H. S. & Lipton, S. A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97, 1611-1626 (2006).
129. Rossi, D. J., Oshima, T. & Attwell, D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316-321 (2000).
130. Choi, D. W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465-469 (1988)
131. Waagepetersen, H. S., Shimamoto, K. & Schousboe, A. Comparison of effects of DL-threo-β-benzyloxyaspartate (DL-TBOA) and L-trans-pyrrolidine- 2, 4-dicarboxylate (t-2, 4-PDC) on uptake and release of [3h]D-aspartate in astrocytes and glutamatergic neurons. Neurochem. Res. 26, 661-666 (2001).
132. Gouix, E., et al. Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation. Mol. Cell. Neurosci. 40, 463-473 (2009).
133. Tu, W., et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140, 222-234 (2010).
134. Milnerwood, A., et al. Early increase in extrasynaptic NMDA receptor signalling and expression contributes to phenotype onset in Huntingtons disease mice. Neuron 65, 178-190 (2010).
135. Subramaniam, S., Sixt, K. M., Barrow, R. & Snyder, S. H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327-1330 (2009).
136. Nucifora, F. C., et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423-2428 (2001).
137. Jiang, H., et al. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. Neurobiol. Dis. 23, 543-551 (2006).
138. McGill, J. K. & Beal, M. F. PGC-1α, a new therapeutic target in Huntingtons disease? Cell 127, 465-468 (2006).
139. St-Pierre, J., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408 (2006).
140. Wareski, P., et al. PGC-1α and PGC-1β regulate mitochondrial density in neurons. J. Biol. Chem. 284, 21379-21385 (2009).
141. Weydt, P., et al. Thermoregulatory and metabolic defects in Huntingtons disease transgenic mice implicate PGC-1α in Huntingtons disease neurodegeneration. Cell Metab. 4, 349-362 (2006).
142. Cui, L., et al. Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69 (2006).
143. Lin, J., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell 119, 121-135 (2004).
144. Muir, K. W. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol. 6, 53-60 (2006).
145. Albers, G. W., Goldstein, L. B., Hall, D. & Lesko, L. M. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA 286, 2673-2682 (2001).
146. Biegon, A., et al. Dynamic changes in N-methyl-Daspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits. Proc. Natl Acad. Sci. USA 101, 5117-5122 (2004).
147. Yaka, R., et al. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury. FASEB J. 21, 2033-2041 (2007).
148. Lipton, S. A. Pathologically activated therapeutics for neuroprotection. Nature Rev. Neurosci. 8, 803-808 (2007).
149. Chen, H. S., et al. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86, 1121-1132 (1998).
150. Xia, P., Chen, H. S., Zhang, D. & Lipton, S. A. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J. Neurosci. 30, 11246-11250 (2010).
151. 2+ imparts NMDA receptor subtype selectivity to the Alzheimers drug memantine. J. Neurosci. 29, 2774-2779 (2009).
152. Chen, S. & Diamond, J. S. Synaptically released glutamate activates extrasynaptic NMDA receptors on cells in the ganglion cell layer of rat retina. J. Neurosci. 22, 2165-2173 (2002).
153. Clark, B. A. & Cull-Candy, S. G. Activity-dependent recruitment of extrasynaptic NMDA receptor activation at an AMPA receptor-only synapse. J. Neurosci. 22, 4428-4436 (2002).
154. Scimemi, A., Fine, A., Kullmann, D. M. & Rusakov, D. A. NR2B-containing receptors mediate cross talk among hippocampal synapses. J. Neurosci. 24, 4767-4777 (2004).
155. Bengtson, C. P., Dick, O. & Bading, H. A quantitative method to assess extrasynaptic NMDA receptor function in the protective effect of synaptic activity against neurotoxicity. BMC Neurosci. 9, 11 (2008).
156. Wu, G. Y., Deisseroth, K. & Tsien, R. W. Activitydependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc. Natl Acad. Sci. USA 98, 2808-2813 (2001).
157. Hardingham, G. E., Arnold, F. J. & Bading, H. A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nature Neurosci. 4, 565-566 (2001).
158. Impey, S., et al. Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34, 235-244 (2002).
159. Screaton, R. A., et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119, 61-74 (2004).
160. Kovacs, K. A., et al. TORC1 is a calcium- and cAMPsensitive coincidence detector involved in hippocampal long-term synaptic plasticity. Proc. Natl Acad. Sci. USA 104, 4700-4705 (2007).
161. Ravnskjaer, K., et al. Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J. 26, 2880-2889 (2007).
162. Luo, Y., Zhu, W., Jia, J., Zhang, C. & Xu, Y. NMDA receptor dependent PGC-1α up-regulation protects the cortical neuron against oxygen-glucose deprivation/ reperfusion injury. J. Mol. Neurosci. 39, 262-268 (2009).